Voluntary Field Correction Action Issued for GE Healthcare’s Resuscitation Systems with Blender, Installed in GE Giraffe and

  Voluntary Field Correction Action Issued for GE Healthcare’s Resuscitation
  Systems with Blender, Installed in GE Giraffe and Panda Infant Warmers

Business Wire

LAUREL, Md. -- January 31, 2013

On October 15, 2012, GE Healthcare initiated a voluntary field corrective
action of the field upgrade kit for GE Healthcare’s resuscitation systems with
blender, installed in GE Giraffe and Panda infant warmers.

The field upgrade kit for GE Healthcare’s resuscitation unit with blender,
used with GE’s Giraffe and Panda infant warmers, may impact patient safety.
The oxygen and air wall inlet fittings and/or labels on the back panel may
have been reversed during assembly. As a result, this could potentially
reverse the air/oxygen mixer concentrations; for example, a setting of 100%
oxygen could have an output of 21% oxygen, and vice versa. The settings of the
blender knob would no longer be accurate.

This voluntary field correction only impacts field upgrade kits for GE
Healthcare’s resuscitation systems with blender, installed in GE’s Giraffe and
Panda infant warmers. The affected resuscitation system upgrade kits were
manufactured from April 2008 to September 2012.

GE Healthcare initiated the field correction on October 15, 2012, and began
notifying customers with affected units through an Urgent Medical Device
Correction letter, which provided instructions and illustrations to allow
hospital personnel to conduct immediate inspection and mitigation, and follow
up has been conducted to confirm their receipt of the letter. GE field service
engineers have inspected units at approximately 89% of the identified customer
sites. The remaining unconfirmed customers are being contacted and scheduled
for inspection by GE field service technicians. To date, no patient injuries
have been reported with this issue.

The U.S. Food and Drug Administration (FDA) has classified this recall as a
Class I recall. FDA defines Class I recalls as “a situation in which there is
a reasonable probability that the use of or exposure to the violative product
will cause serious adverse health consequences or death.”

For additional information regarding this field action, please contact GE
Healthcare Customer Service at 1-800-345-2700.

About GE Healthcare

GE Healthcare provides transformational medical technologies and services that
are shaping a new age of patient care. Our broad expertise in medical imaging
and information technologies, medical diagnostics, patient monitoring systems,
drug discovery, biopharmaceutical manufacturing technologies, performance
improvement and performance solutions services help our customers to deliver
better care to more people around the world at a lower cost. In addition, we
partner with healthcare leaders, striving to leverage the global policy change
necessary to implement a successful shift to sustainable healthcare systems.

Our "healthymagination" vision for the future invites the world to join us on
our journey as we continuously develop innovations focused on reducing costs,
increasing access and improving quality and efficiency around the world.
Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of
General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more
than 46,000 people committed to serving healthcare professionals and their
patients in more than 100 countries. For more information about GE Healthcare,
visit our web site at www.gehealthcare.com.

Contact:

GE Healthcare
Annette Busateri
+1-262-442-0966
annette.busateri@ge.com
 
Press spacebar to pause and continue. Press esc to stop.